Abbott (NYSE:ABT) today shared new clinical trial findings supporting its Aveir AR leadless atrial pacemaker system.
Dr. Zhuoshan Huang: A 79-year-old man was admitted to the Third Affiliated Hospital of Sun Yat-sen University in Guangzhou, China, because of dyspnea and edema in the arms and legs. The patient had ...
The 338 enrolled patients resulted in a potential for 676 leads to be implanted. Of the 676 leads, implantation was abandoned in 8 leads (three patients with exclusion criteria, two patients with ...
Harish Manyam, MD, chief of cardiology at Erlanger and Chair of Medicine for the University of Tennessee Health Science Center College of Medicine – Chattanooga, completed Tennessee’s first atrial ...
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...
PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ventricle ...
The rhythm is regular at a rate of 78 beats/min. Before each QRS complex, there are two pacing stimuli (+,v) with a very short interval (0.06 sec) between them. They are both ventricular pacing ...
Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...
If you have an irregular heartbeat, you may benefit from a new pacemaker device that doctors say has much fewer complications than traditional pacemakers. A survivor of polio, Barbara Wade has atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results